Vancomycin MIC plus heteroresistance and outcome of methicillin-resistant Staphylococcus aureus bacteremia: Trends over 11 years

Journal of Clinical Microbiology

Volumn 47, Issue 6, 2009, Pages 1640-1644

  Musta, Adina C ^a   Riederer, Kathleen ^a   Shemes, Stephen ^a   Chase, Patrick ^a   Jose, Jinson ^a   Johnson, Leonard B ^a   Khatib, Riad ^a,b  

^a ST JOHN HOSPITAL AND MEDICAL CENTER   (United States)

^b St John Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VANCOMYCIN;

ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATION; COMPARATIVE STUDY; CONTROLLED STUDY; EPSILOMETER TEST; FEMALE; GENE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEC GENE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MINIMUM INHIBITORY CONCENTRATION; MORTALITY; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL;

ANTI-BACTERIAL AGENTS; BACTEREMIA; BACTERIAL TYPING TECHNIQUES; CHROMOSOMES, BACTERIAL; CLUSTER ANALYSIS; DNA FINGERPRINTING; EPIDEMIOLOGY, MOLECULAR; GENOTYPE; HUMANS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; STAPHYLOCOCCAL INFECTIONS; TREATMENT OUTCOME; VANCOMYCIN RESISTANCE;

METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS AUREUS;

EID: 66749117782     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.02135-08     Document Type: Article

References (45)

1. Appelbaum, P. C. 2007. Microbiology of antibiotic resistance in Staphylococcus aureus. Clin. Infect. Dis. 45:S165-S170.
2. Benquan, W., T. Yingchun, Z. Kouxing, Z. Tiantuo, Z. Jiaxing, and T. Shuqing. 2002. Staphylococcus heterogeneously resistant to vancomycin in China and antimicrobial activities of imipenem and vancomycin in combination against it. J. Clin. Microbiol. 40:1109-1112.
3. Boyle-Vavra, S., S. K. Berke, J. C. Lee, and R. S. Daum. 2000. Revision of glycopeptide resistance phenotype in Staphylococcus aureus clinical isolate. Antimicrob. Agents Chemother. 44:272-277.
4. Charles, P. G. P., P. B. Ward, P. D. R. Johnson, B. P. Howden, and L. Grayson. 2004. Clinical features associated with bacteremia due to heterogeneous vancomycin-intermediate Staphylococcus aureus. Clin. Infect. Dis. 38:448-451. (Pubitemid 38200128)
5. Chua, T., C. L. Moore, M. B. Perri, S. M. Donabedian, W. Masch, D. Vagar, S. L. Davis, K. Lulek, B. Zimnicki, and M. J. Zervos. 2008. Molecular epidemiology of methicillin-resistant Staphylococcus aureus bloodstream isolates in urban Detroit. J. Clin. Microbiol. 46:2345-2352.
6. Delgado, A., J. T. Riordan, R. Lamichhane-Khadka, D. C. Winnett, J. Jimenez, K. Robinson, F. G. O'Brien, S. A. Cantore, and G. E. Gustafson. 2007. Hetero-vancomycin-intermediate methicillin-resistant Staphylococcus isolate from medical center in Las Cruces, New Mexico. J. Clin. Microbiol. 45:1325-1329.
7. Deresinski. S. 2007. Counterpoint: vancomycin and Staphylococcus aureus - an antibiotic enters obsolescence. Clin. Infect. Dis. 44:1543-1548.
8. Falagas, M. E., G. C. Makris, G. Dimopoulos, and D. K. Matthaiou. 2008. Heteroresistance: a concern of increasing clinical significance? Clin. Microbiol. Infect. 14:101-104.
9. Ferreira Nunez, A. P., R. P. Schuenck, C. C. Reis Bastos, M. M. Magnanini, J. B. Long, N. L. Iorio, and K. R. Santos. 2007. Heterogeneous resistance to vancomycin and teicoplanin among Staphylococcus spp. isolated from bacteremia. Brazil. J. Infect. Dis. 11:345-350.
10. Fridkin, S. K., J. Hageman, L. K. McDougal, J. Mohammed, W. R. Jarvis, T. M. Perl, F. C. Tenover, and Vancomycin-Intermediate Staphylococcus aureus Epidemiology Study Group. 2003. Epidemiological and microbiological characterization of infection caused by Staphylococcus aureus with reduced susceptibility to vancomycin, United States, 1997-2001. Clin. Infect. Dis. 36:429-439.
11. Hiramatsu, K., N. Aritaka, H. Hanaki, S. Kawasaki, Y. Hosoda, S. Hori, Y. Fukuchi, and I. Kobayashi. 1997. Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin. Lancet 350:1670-1673.
12. Howden, B. P. 2005. Recognition and management of infections caused by vancomycin-intermediate Staphylococcus aureus (VISA) and heterogeneous VISA (hVISA). Int. Med. J. 35:S136-S140.
13. Howden, B. P., P. B. Ward, J. Robson, A. J. Morris, B. C. Mayall, and M. L. Grayson. 2004. Treatment outcomes for serious infections caused by methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility. Clin. Infect. Dis. 38:521-528.
14. Hussain, F., S. Boyle-Vavra, P. B. Shete, and R. S. Daum. 2002. Evidence for continuum of decreased vancomycin susceptibility in unselected Staphylococcus clinical isolates. Clin. Infect. Dis. 186:661-667.
15. Jones, R. N. 2006. Microbiological features of vancomycin in the 21st century: minimum inhibitory concentration creep, bactericidal/static activity, and applied breakpoints to predict clinical outcomes or detect resistant strains. Clin. Infect. Dis. 42:S13-S24.
16. Khatib, R., L. B. Johnson, M. Sharma, M. G. Fakih, R. Ganga, and K. Riederer. 2009. Persistent Staphylococcus aureus bacteremia: incidence and outcome trends over time. Scand. J. Infect. Dis. 41:4-9.
17. Khatib, R., K. Riederer, S. Saeed, L. B. Johnson, M. G. Fakih, M. Sharma, M. S. Tabriz, and A. Khosrovaneh. 2005. Time to positivity in Staphylococcus aureus bacteremia: possible correlation with the source and outcome of infection. Clin. Infect. Dis. 41:594-598.
18. Khatib, R., M. Sharma, A. H. Naqvi, K. Riederer, M. O. Almoujahed, and M. G. Fakih. 2003. Molecular analysis of Staphylococcus aureus blood isolates shows lack of polyclonal bacteremia. J. Clin. Microbiol. 41:1717-1719.
19. Khosrovaneh, A., K. Riederer, S. Saeed, M. Sharma, L. B. Johnson, M. Fakih, and R. Khatib. 2004. Frequency of reduced vancomycin susceptibility and heterogeneous subpopulation in persistent or recurrent methicillin resistant Staphylococcus aureus bacteremia. Clin. Infect. Dis. 38:1328-1330.
20. Kim, H. B., W. B. Park, K. D. Lee, Y. J. Choi, S. W. Park, M. D. Oh, E. C. Kim, and K. W. Choe. 2003. Nationwide surveillance for Staphylococcus aureus with reduced susceptibility to vancomycin in Korea. J. Clin. Microbiol. 41:2279-2281.
21. Kim, M. N., S. H. Hwang, Y. J. Pyo, H. M. Mun, and C. H. Pai. 2002. Clonal spread of Staphylococcus aureus heterogeneously resistant to vancomycin in a university hospital in Korea. J. Clin. Microbiol. 40:1376-1380.
22. Klevens, R. M., M. A. Morrison, J. Nadle, S. Petit, K. Gersham, S. Ray, L. H. Harrison, R. Lynfield, G. Dumyati, J. M. Townes, A. S. Craig, E. R. Zell, G. E. Fosheim, L. K. McDougal, R. B. Carey, and S. K. Fridkin. 2007. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 298:1763-1771. (Pubitemid 47598444)
23. Li, J. S., D. J. Sexton, N. Mick, R. Nettle, V. G. Fowler, Jr., T. Ryan, T. Bashore, and G. R. Corey. 2006. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin. Infect. Dis. 30:633-638.
24. Liu, C., and H. F. Chambers. 2003. Staphylococcus aureus with heterogeneous resistance to vancomycin: epidemiology, clinical significance, and critical assessment of diagnostic methods. Antimicrob. Agents. Chemother. 47:3040-3045.
25. Lodise, T. P., J. Graves, A. Evans, E. Graffunder, M. Helmecke, B. M. Lomaestro, and K. Stellrecht. 2008. Relationship between vancomycin MIC and failure among patients with methicillin-resistant Staphylococcus aureus bacteremia treated with vancomycin. Antimicrob. Agents Chemother. 52: 3315-3320.
26. Maor, Y., M. Hagin, N. Belausov, N. Keller, D. Ben-David, and G. Rahav. 2009. Clinical features of heteroresistant vancomycin-intermediate Staphylococcus aureus bacteremia versus those of methicillin-resistant S. aureus bacteremia. J. Infect. Dis. 199:619-624.
27. Maor, Y., G. Rahav, N. Belausov, D. Ben-David, G. Smollan, and N. Keller. 2007. Prevalence and characteristics of heteroresistant vancomycin-intermediate Staphylococcus aureus bacteremia in a tertiary care center. J. Clin. Microbiol. 45:1511-1514.
28. Marchese, A., G. Balistreri, E. Tonoli, E. A. Debbia, and G. C. Schito. 2000. Heterogeneous vancomycin resistance in methicillin-resistant Staphylococcus strains isolated in a large Italian hospital. J. Clin. Microbiol. 38:866-869.
29. Mohr, J. F., and B. E. Murray. 2007. Point: vancomycin is not obsolete for the treatment of infections caused by methicillin resistant Staphylococcus aureus. Clin. Infect. Dis. 44:1536-1542. (Pubitemid 46871498)
30. Moise, P. A., A. Sakoulas, A. Forrest, and J. J. Schentag. 2007. Vancomycin in vitro bactericidal activity and its relationship to efficacy in clearance of methicillin-resistant Staphylococcus aureus bacteremia. Antimicrob. Agents Chemother. 51:2582-2586.
31. Plipat, N., G. Livni, H. Bertram, and R. B. Thomson, Jr. 2005. Unstable heteroresistance is common among clinical isolates of methicillin-resistant Staphylococcus aureus. J. Clin. Microbiol. 43:2494-2496.
32. Prakash, V., J. S. Lewis II, and J. H. Jorgensen. 2008. Vancomycin MICs for methicillin-resistant Staphylococcus aureus isolates differ based upon the susceptibility test method used. Antimicrob. Agents Chemother. 52:4528.
33. Ross, T. L., W. G. Merz, M. Farkosh, and K. C. Carroll. 2005. Comparison of automated repetitive sequence-based PCR microbial typing system to pulse-field gel electrophoresis for analysis of outbreaks of methicillin-resistant Staphylococcus aureus. J. Clin. Microbiol. 43:5642-5647. (Pubitemid 41612342)
34. Rybak, M. J., S. N. Leonard, K. L. Rossi, C. M. Cheung, H. S. Sadar, and R. N. Jones. 2008. Characterization of vancomycin heteroresistant Staphylococcus aureus (hVISA) from the Detroit metropolitan area over 22-year period (1986-2007). J. Clin. Microbiol. 46:2950-2954.
35. Sakoulas, G., P. A. Moise-Broder, J. Schentag, A. Forrest, R. C. Mollering, Jr., and G. M. Eliopoulos. 2004. Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia. J. Clin. Microbiol. 42:2398-2402.
36. Schwaber, M. J., S. B. Wright, Y. Carmeli, L. Venkataraman, P. C. De-Girolami, A. Gramatikova, T. M. Perl, G. Sakoulas, and H. S. Gold. 2003. Clinical implications of varying degrees of vancomycin susceptibility in methicillin-resistant Staphylococcus aureus bacteremia. Emerg. Infect. Dis. 9:657-664.
37. Soriano, A., F. Marco, A. J. Martinez, E. Pisos, M. Almela, V. P. Dimova, D. Alamo, M. Ortega, J. Lopez, and J. Mensa. 2008. Influence of vancomycin minimal inhibitory concentration on the treatment of methicillin resistant Staphylococcus aureus bacteremia. Clin. Infect. Dis. 46:193-200.
38. Steinkraus, G., R. White, and L. Friedrich. 2007. Vancomycin MIC creep in non-vancomycin-intermediate Staphylococcus aureus (VISA) vancomycin-susceptible clinical methicillin-resistant S. aureus (MRSA) blood isolates from 2001-05. J. Antimicrob. Chemother. 60:788-794.
39. Tenover, F., and R. C. Moellering, Jr. 2007. The rationale for revising the Clinical and Laboratory Standards Institute vancomycin minimal inhibitory concentration interpretive criteria for Staphylococcus aureus. Clin. Infect. Dis. 44:1208-1215.
40. Walsh, T. R., A. Bolmstrom, A. Qwarnstrom, P. Ho, M. Wootton, R. A. Howe, A. P. MacGowan, and D. Diekema. 2001. Evaluation of current methods for detection of staphylococci with reduced susceptibility to glycopeptides. J. Clin. Microbiol. 39:2439-2444.
41. Walsh, T. R., and R. A. Howe. 2002. The prevalence and mechanism of vancomycin resistance in Staphylococcus aureus. Annu. Rev. Microbiol. 56: 657-675.
42. Wang, G., J. F. Hindler, K. W. Ward, and D. A. Bruckner. 2006. Increased vancomycin MICs for Staphylococcus aureus clinical isolates from a university hospital during a 5-year period. J. Clin. Microbiol. 44:3883-3886.
43. Wong, S. S., P. L. Ho, P. C. Woo, and K. Y. Yuen. 1999. Bacteremia caused by Staphylococcus aureus with inducible vancomycin heteroresistance. Clin. Infect. Dis. 29:760-767.
44. Wootton, M., A. P. MacGowan, T. R. Walsh, and R. A. Howe. 2007. A multicenter study evaluating the current strategies for isolating Staphylococcus aureus strains with reduced susceptibility to glycopeptides. J. Clin. Microbiol. 45:329-332.
45. Zhang, K., J. A. McClure, S. Elsayed, T. Louie, and J. M. Conly. 2005. Novel multiplex PCR assay for characterization and concomitant subtyping of staphylococcal cassette chromosome mec types I to V in methicillin-resistant Staphylococcus aureus. J. Clin. Microbiol. 43:5026-5033. (Pubitemid 41483999)